Impact of Advanced Hybrid Closed Loop on Youth With High-Risk Type 1 Diabetes Using Multiple Daily Injections.
Alisa BoucseinAntony S WatsonCarla M FrewenOlivia J SandersJillian Joy HaszardShirley D JonesPhilippa J Milford-HughesMartin I de BockBenjamin John WheelerPublished in: Diabetes care (2023)
AHCL has the potential to improve suboptimal glycemia in youth with type 1 diabetes previously on MDI therapy.